Aerosolization apparatus with capsule puncture alignment guide

Details for Australian Patent Application No. 2004229512 (hide)

Owner Novartis AG

Inventors Glusker, Mark J.; Vernon-Harcourt, Edward William; Paboojian, Steve; Tuckwell, Jonathan David; Dunkley, Michael John

Agent Griffith Hack

Pub. Number AU-B-2004229512

PCT Pub. Number WO2004/091707

Priority 60/461,748 09.04.03 US

Filing date 9 April 2004

Wipo publication date 28 October 2004

Acceptance publication date 11 February 2010

International Classifications

A61M 15/00 (2006.01) Inhaling devices

Event Publications

13 October 2005 PCT application entered the National Phase

  PCT publication WO2004/091707 Priority application(s): WO2004/091707

16 July 2009 Assignment before Grant

  Nektar Therapeutics The application has been assigned to Novartis AG

11 February 2010 Application Accepted

  Published as AU-B-2004229512

10 June 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004229513-The preparation of titania and cobalt aluminate catalyst supports and their use in Fischer-Tropsch synthesis

2004229507-Polymorphic form of montelukast sodium